Amber Chevalier

Amber Chevalier is a seasoned professional with extensive experience in clinical programs and genetic counseling. Currently serving as VP of Clinical Programs at NeoGenomics Laboratories since September 2022, Amber has previously held key roles in medical affairs at Invitae, focusing on somatic oncology and tumor profiling, and at Guardant Health, specializing in liquid biopsies. Previous experience includes serving as a genetic counselor at GeneDx and the University of Nebraska Medical Center, where work centered on inherited cancer and molecular variant analysis. Educational qualifications include a Bachelor of Arts in English from the University of Virginia and a Master of Science in Genetic Counseling from the University of Pittsburgh, along with a study abroad experience in Irish Studies at University College Cork.